Regional distribution and clinical correlates of white matter structural damage in Huntington disease: A tract-based spatial statistics study

American Journal of Neuroradiology

Volumn 31, Issue 9, 2010, Pages 1675-1681

  Della Nave, R ^a   Ginestroni, A ^b   Tessa, C ^c   Giannelli, M ^d   Piacentini, S ^b   Filippi, M ^e   Mascalchi, Mario ^b  

^a SAN GIUSEPPE HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Versilia Hospital   (Italy)

^d Dept of Clin Microbiol Lab   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CEREBRAL PEDUNCLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DIFFUSION WEIGHTED IMAGING; DISEASE DURATION; FEMALE; FRACTIONAL ANISOTROPY; HEMISPHERE; HUMAN; HUNTINGTON CHOREA; MALE; VOXEL BASED MORPHOMETRY; WHITE MATTER;

ADULT; AGED; BRAIN; DATA INTERPRETATION, STATISTICAL; DIFFUSION TENSOR IMAGING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC;

EID: 77958523808     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2128     Document Type: Article

References (40)

1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome: The Huntington's Disease Collaborative Research Group. Cell 1993;72:971-83
2. de la Monte SM, Vonsattel JP, Richardson EP Jr. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 1988;47:516-25
3. Thieben MJ, Duggins AJ, Good CD, et al. The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 2002;125:1815-28
4. Beglinger LJ, Nopoulos PC, Jorge RE, et al. White matter volume and cognitive dysfunction in early Huntington's disease. Cogn Behav Neurol 2005;18:102-07
5. Ciarmiello A, Cannella M, Lastoria S, et al. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. J Nucl Med 2006;47:215-22 (Pubitemid 46780885)
6. Tabrizi SJ, Langbehn DR, Leavitt BR, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of the baseline data. Lancet Neurol 2009;8:791-801
7. Aylward EH, Anderson NB, Bylsma FW, et al. Frontal lobe volume in patients with Huntington's disease. Neurology 1998;50:252-58
8. Fennema-Notestine C, Archibald SL, Jacobson MW, et al. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology 2004;63:989-95 (Pubitemid 39287905)
9. Gavazzi C, Della Nave R, Petralli R, et al. Combining functional and structural MR imaging of the brain in Huntington disease. J Comput Assist Tomogr 2007;31:574-80 (Pubitemid 47457673)
10. Mascalchi M, Lolli F, Della Nave R, et al. Volumetric, diffusion and magnetization transfer MR imaging of the brain in individuals with Huntington's disease. Radiology 2004;232:867-73
11. Reading SA, Yassa MA, Bakker A, et al. Regional white matter changes in presymptomatic Huntington's disease. J Psychiat Res 2005;140:55-62
12. Rosas HD, Tuch DS, Hevelone ND, et al. Diffusion tensor imaging in presymptomatic and early Huntington's disease: selective white matter pathology and its relationship to clinical measures. Mov Disord 2006;21:1317-25
13. Klöppel S, Draganski B, Golding CV, et al. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. Brain 2008;131:196-204
14. Weaver KE, Richards TL, Liang O, et al Longitudinal diffusion tensor imaging in Huntington's disease. Exp Neurol 2009;216:525-29
15. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487-505 (Pubitemid 43913517)
16. Smith SM, Johansen-Berg H, Jenkinson M, et al. Acquisition and voxelwise analysis of multi-subject diffusion data with tract-based spatial statistics. Nat Protoc 2007;3:499-503
17. Della Nave R, Ginestroni A, Tessa C, et al. Brain white matter tracts degeneration in Friedreich ataxia: an in vivo MRI study using tract-based spatial statistics and voxel based morphometry. Neuroimage 2008;40:19-25
18. Della Nave R, Ginestroni A, Tessa C, et al. Brain white matter damage in SCA1 and SCA2: an in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics. Neuroimage 2008;43:10-19
19. Muglia M, Leone O, Annesi G, et al. Nonisotopic method for accurate detection of (CAG)n repeats causing Huntington disease. Clin Chem 1996;42:1601-03
20. Rubinsztein DC, Leggo J, Coles R, et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 1996;59:16-22
21. Unified Huntington's Disease Rating Scale: reliability and consistency - Huntington Study Group. Mov Disord 1996;11:136-42
22. Rosas HD, Salat DH, Lee SY, et al. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain 2008;131:1057-68
23. Treisman A, Fearnley S. The Stroop test: selective attention to colours and words. Nature 1969;222:437-39
24. Wechsler D. Manual for the Wechsler Adult Intelligence Scale-Revised. New York: The Psychological Corp; 1981
25. Shoulson I, Fahn S. Huntington disease: clinical care and evaluation. Neurology 1979;29:1-3
26. Behrens TE, Woolrich MW, Jenkinson M, et al. Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med 2003;50:1077-88 (Pubitemid 37356588)
27. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23:208-19
28. Good CD, Johnsrude IS, Ashburner J, et al. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001;14:21-36
29. Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp 2002;15:1-25
30. Mori S, Wakana S, van Zijl PC, et al. MRI Atlas of Human White Matter. Amsterdam, the Netherlands: Elsevier; 2005
31. Kassubek J, Juengling FD, Kioschies T, et al. Topography of cerebral atrophy in early Huntington's disease: a voxel-based morphometric MRI study. J Neurol Neurosurg Psychiatry 2004;75:213-20
32. Muhlau M, Weindl A, Wolschlager AM, et al. Voxel-based morphometry indicates relative preservation of the limbic prefrontal cortex in early Huntington disease. J Neural Transm 2007;114:367-72
33. Budde MD, Kim JH, Liang HF, et al. Toward accurate diagnosis of white matter pathology using diffusion tensor imaging. Magn Reson Med 2007;57:688-95
34. Schmahmann JD, Pandya DN. Fibre Pathways of the Brain. New York: Oxford University Press; 2006
35. Cosottini M, Giannelli M, Siciliano G, et al. Diffusion-tensor MR imaging of corticospinal tract in amyotrophic lateral sclerosis and progressive muscular atrophy. Radiology 2005;237:258-64
36. Pierpaoli C, Barnett A, Pajevic S, et al. Water diffusion changes in wallerian degeneration and their dependence on white matter architecture. Neuroimage 2001;13:1174-85
37. Jech R, Klempff J, Vymazal J, et al. Variation of selective gray and white matter atrophy in Huntington's disease. Mov Disord 2007;22:1783-89
38. Peinemann A, Schuller S, Pohl C, et al. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study. J Neurol Sci 2005;239:11-19
39. Goldberg E, Bougakov D. Neuropsychological assessment of frontal lobe dysfunction. Psychiatr Clin North Am 2005;28:567-80
40. Usiskin SI, Bainbridge A, Miller RF, et al. Progressive multifocal leukoencephalopathy: serial high b-value diffusion-weighted MR imaging and apparent diffusion coefficient measurements to assess response to highly active antiretroviral therapy. AJNR Am J Neuroradiol 2007;28:285-86